Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results

Inhibrx, Inc. (INBX) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 8-K Quarterly results
Docs: "Inhibrx Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights",
"14 2821 40 100 60 80 20 0 0 7"
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
05/25/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/08/2023 8-K Quarterly results
Docs: "Inhibrx Reports First Quarter 2023 Financial Results and Recent Corporate Highlights"
05/08/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/26/2023 8-K Quarterly results
04/13/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/13/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/06/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/06/2023 8-K Quarterly results
Docs: "Inhibrx Reports Fourth Quarter and Fiscal Year 2022 Financial Results",
"HD 1H 2024 INBRX-109 INBRX-105"
03/06/2023 10-K Annual Report for the period ended December 31, 2022
03/02/2023 4 Eckelman Brendan P. (Chief Scientific Officer) has filed a Form 4 on Inhibrx, Inc.
Txns: Sold 39,600 shares @ $24.2007, valued at $958.3k
Sold 400 shares @ $24.7075, valued at $9.9k
03/01/2023 4 Lappe Mark (CEO) has filed a Form 4 on Inhibrx, Inc.
Txns: Sold 60 shares @ $25.0208, valued at $1.5k
02/14/2023 SC 13G/A RA CAPITAL MANAGEMENT, L.P. reports a 8.9% stake in INHIBRX, INC.
02/14/2023 SC 13G/A PERCEPTIVE ADVISORS LLC reports a 7.6% stake in Inhibrx, Inc.
02/14/2023 SC 13G/A VIKING GLOBAL INVESTORS LP reports a 15.2% stake in Inhibrx, Inc.
02/08/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/03/2023 SC 13G BlackRock Inc. reports a 5.5% stake in Inhibrx, Inc.
02/02/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/24/2023 4 Lappe Mark (CEO) has filed a Form 4 on Inhibrx, Inc.
Txns: Sold 21,665 shares @ $25.3572, valued at $549.4k
Sold 4,272 shares @ $25.71, valued at $109.8k
Sold 63 shares @ $26.1127, valued at $1.6k
01/23/2023 4 Kayyem Jon Faiz (Director) has filed a Form 4 on Inhibrx, Inc.
Txns: Sold 9,500 shares @ $25.2631, valued at $240k
01/04/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/03/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/22/2022 4 Kayyem Jon Faiz (Director) has filed a Form 4 on Inhibrx, Inc.
Txns: Sold 7,541 shares @ $26.8653, valued at $202.6k
Sold 1,959 shares @ $27.6099, valued at $54.1k
12/20/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/22/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/16/2022 8-K Quarterly results
11/07/2022 8-K Quarterly results
11/07/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/02/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/26/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy